1-1 of 1
Nicola Wallis, MRCPath, FFPM
Close
Sort by
Journal Articles

Economic Burden of Adverse Events Among Patients with Chronic Myelogenous Leukemia Treated with BCR-ABL1 Tyrosine Kinase Inhibitors

Jay Lin, PhD MBA, Makenbaeva Dinara, MD MBA, Bilmes Robyn, PharmD, BCOP, Melissa Lingohr-Smith, PhD, Nicola Wallis, MRCPath, FFPM
Journal: Blood
Blood (2015) 126 (23): 876.
https://doi.org/10.1182/blood.V126.23.876.876
Published: 2015